GENERIC 19773432

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0011065, umls-concept:C0013081, umls-concept:C0205198, umls-concept:C0334227, umls-concept:C0920591, umls-concept:C1413357, umls-concept:C2349975
pubmed:issue	19
pubmed:dateCreated	2009-10-2
pubmed:abstractText	Smac mimetic compounds (SMC) are novel small molecules being developed for cancer therapy. The mechanism of SMC-induced sensitivity in cancer cells depends on autocrine release of tumor necrosis factor alpha (TNFalpha); however, potential mechanisms of resistance remain unknown. Here, we investigated the molecular profile and cytotoxic responsiveness of a diverse panel of 51 cancer cell lines to combinations of a dimeric SMC (AEG40730), death ligand TNFalpha, and tumor necrosis factor-related apoptosis-inducing ligand. Synergy was seen in combination with death receptor agonists in some cells, although single-agent activity was limited to a fewsensitive lines. Unexpectedly, the majority of cell lines resistant to combinations of SMC-AEG40730 and death ligands expressed caspase-8, FADD, RIP1, and ligand receptors necessary for apoptosis execution. Furthermore, TNFalpha-mediated ubiquitination of RIP1 was repressed by SMC-AEG40730 treatment, leading to the formation of the proapoptosis complex II. However, in resistant cancer cells, SMC-AEG40730 repressed TNFalpha-mediated c-jun-NH(2)-kinase activation and the levels of caspase-8 inhibitor c-FLIP were persistently elevated, in contrast to SMC-responsive cancer cells. Importantly, the silencing of c-FLIP restored SMC sensitivity in previously resistant cancer cells by allowing ligand-mediated activation of caspase-8 and caspase-3 to proceed. Together, these results provide mechanistic insight into the action of SMCs, demonstrating that the deciphering of the relevant molecular signature in cancer cells leads to the prediction of cancer cell responsiveness to SMC treatment. Furthermore, a majority of resistant cancer cells were sensitized to SMC-AEG40730 and TNFalpha by down-regulating c-FLIP, suggesting novel approaches in the use of SMCs and c-FLIP antagonists in treating cancer.
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/2984705R
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/AEG 40730, http://linkedlifedata.com/resource/pubmed/chemical/AGFG1 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Alkynes, http://linkedlifedata.com/resource/pubmed/chemical/CASP8 and FADD-Like Apoptosis..., http://linkedlifedata.com/resource/pubmed/chemical/Dipeptides, http://linkedlifedata.com/resource/pubmed/chemical/NF-kappa B, http://linkedlifedata.com/resource/pubmed/chemical/Nuclear Pore Complex Proteins, http://linkedlifedata.com/resource/pubmed/chemical/RNA-Binding Proteins, http://linkedlifedata.com/resource/pubmed/chemical/TNF-Related Apoptosis-Inducing..., http://linkedlifedata.com/resource/pubmed/chemical/TNFSF10 protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Tumor Necrosis Factor-alpha
pubmed:status	MEDLINE
pubmed:month	Oct
pubmed:issn	1538-7445
pubmed:author	pubmed-author:CheungHerman HHH, pubmed-author:KornelukRobert GRG, pubmed-author:LacasseEric CEC, pubmed-author:MahoneyDouglas JDJ
pubmed:issnType	Electronic
pubmed:day	1
pubmed:volume	69
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	7729-38
pubmed:dateRevised	2010-9-20
pubmed:meshHeading	pubmed-meshheading:19773432-Alkynes, pubmed-meshheading:19773432-Apoptosis, pubmed-meshheading:19773432-Breast Neoplasms, pubmed-meshheading:19773432-CASP8 and FADD-Like Apoptosis Regulating Protein, pubmed-meshheading:19773432-Cell Line, Tumor, pubmed-meshheading:19773432-Dipeptides, pubmed-meshheading:19773432-Down-Regulation, pubmed-meshheading:19773432-Drug Resistance, Neoplasm, pubmed-meshheading:19773432-Drug Screening Assays, Antitumor, pubmed-meshheading:19773432-Drug Synergism, pubmed-meshheading:19773432-Humans, pubmed-meshheading:19773432-NF-kappa B, pubmed-meshheading:19773432-Neoplasms, pubmed-meshheading:19773432-Neuroblastoma, pubmed-meshheading:19773432-Nuclear Pore Complex Proteins, pubmed-meshheading:19773432-RNA-Binding Proteins, pubmed-meshheading:19773432-Signal Transduction, pubmed-meshheading:19773432-TNF-Related Apoptosis-Inducing Ligand, pubmed-meshheading:19773432-Tumor Necrosis Factor-alpha, pubmed-meshheading:19773432-Ubiquitination
pubmed:year	2009
pubmed:articleTitle	Down-regulation of c-FLIP Enhances death of cancer cells by smac mimetic compound.
pubmed:affiliation	Apoptosis Research Centre, Children's Hospital of Eastern Ontario Research Institute and Department of Biochemistry, Microbiology and Immunology, University of Ottawa, Ottawa, Ontario, Canada.
pubmed:publicationType	Journal Article, Research Support, Non-U.S. Gov't